Follow the latest coverage, related explainers and connected technology stories.
Guardant Health is seeking to expand use of the Shield test for colorectal cancer detection while developing a new generation designed to improve its ability to detect early-stage disease and precancerous lesions. The company is also working on a multicancer test covering 10 types, but it still needs to gather additional evidence before seeking FDA approval.